A few weeks ago, I released two videos
on the general effectiveness of chemotherapy.
What happens when you add fasting to the mix?
This is the first of a 3-video series exploring that very question.
"Fasting Before and After Chemotherapy and Radiation"
For the past 50 years, chemotherapy has been a major medical treatment
for a wide range of cancers.
Its main strategy has been largely based on targeting cancer cells,
by means of DNA damage caused in part by the
production of free radicals.
Although these drugs were first believed to be
quite selective for tumor cells,
we now know that normal cells also experience severe
chemotherapy-dependent damage, leading to dose-limiting side effects
including bone marrow and immune system suppression,
fatigue, vomiting, diarrhea, and in some cases even death.
And if you do survive, the DNA damage to normal cells
can even lead to new cancers down the road.
There are cell-protecting drugs that have been tried
to reduce the side effects,
so you can pump in higher chemo doses,
but these drugs have not been shown to increase survival,
in part because they may also be protecting the cancer cells.
What about instead using fasting
for cellular protection during cancer treatment?
Fasting may have an unrecognized role
in cancer prevention and treatment.
Short-term fasting before and immediately after chemotherapy
may minimize side effects, while at the same time
may actually make cancer cells more sensitive to treatment.
That's exciting.
During nutrient deprivation, healthy cells switch from growth
to maintenance and repair, but tumor cells are unable
to slow down their unbridled growth due to growth-promoting mutations
that led them to become cancer cells in the first place.
This inability to adapt to starvation may represent an important
Achilles' heel for many types of cancer cells.
As a consequence of these differential responses
of healthy versus cancer cells to short-term fasting,
chemotherapy causes more DNA damage and cell suicide
in tumor cells, while potentially leaving healthy cells unharmed.
Thus, short-term fasting may protect healthy cells
against the toxic properties of chemotherapy
and render tumor cells more sensitive,
or at least that's the theory. Let's test it out.
Tyrosine kinase inhibitors are a group of chemo drugs
that are now the mainstay of treatment in many types of cancer.
Let's see them in action.
These are petri dishes filled with cancer cells that
have been dyed pink.
Two types of lung cancer cells and one type of colorectal cancer.
This is the before, and this the after, exposed to the chemo drugs
erlotinib, gefitinib, crizotinib, and regorafenib.
See how there's less pink?
That shows how many cancer cells the chemo killed off.
Starve the cells for 24 hours first, though,
and the drugs work even better.
Even the starvation alone without the drugs killed off a bunch of them.
The researchers conclude that these TKI drugs that are
commonly administrated for treating solid tumors become
potentiated in their activity by 24 hours of starvation,
but that's in a petri dish.
Similar results were found for breast cancer and
a chemo drug called doxorubicin.
Here's five days of unhindered growth of breast cancer in a petri dish,
from 150,000 cancer cells to 800,000 in under a week.
Dripping on a little chemo can knock it down to around 600,000,
but starve those cells for 48 hours first,
and the chemo can completely keep them in check.
Even the short-term starvation alone can restrain growth.
Short-term fasting raises the possibility that you could get
twice the effect for half the dose, which may be particularly important
for a drug as toxic as doxorubicin, which causes heart failure
in as many as 1 in 3 at higher doses.
Again, though, these are just in vitro studies in a petri dish
Then researchers moved to mice and found the same dual benefit:
less toxic chemo, yet at the same time
more effective, and not just by a little.
A high enough chemo dose to kill 100% in less than a week.
But after being starved for 60 hours, after the same dose, 100% survived.
Ok, that's the toxicity. What about efficacy?
Here's tumor growth without chemo, growth with chemo,
and with chemo after short-term fasting,
and this translated into improved survival.
Interestingly, fasting alone appeared to work
as well as the chemo, and the same with radiation.
Unbridled tumor growth knocked down by radiation therapy,
and even more so after the combination of radiation
and alternate-day fasting,
but alternate-day fasting alone seemed to do as well as the radiation.
OK, but that's breast cancer in mice.
I'm sure Mickey is thrilled for Minnie, but what about in people?
We'll explore that next.